CHOLIB

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Hong Kong SAR China, Ireland, Lithuania, Poland, Singapore, UK.

Active ingredients

The drug CHOLIB contains a combination of these active pharmaceutical ingredients (APIs):

1	Fenofibrate UNII U202363UOS - FENOFIBRATE
	Fenofibrate is a fibric acid derivative whose lipid modifying effects reported in humans are mediated via activation of Peroxisome Proliferator Activated Receptor type α (PPARα). Through activation of PPARα, fenofibrate increases lipolysis and elimination of atherogenic triglyceride rich particles from plasma by activating lipoprotein lipase and reducing production of Apoprotein C-III.
	Read more about Fenofibrate
2	Simvastatin UNII AGG2FN16EV - SIMVASTATIN
	Simvastatin has a potent activity in inhibiting HMG-CoA reductase (3-hydroxy–3-ethylglutaryl-CoA-reductase). Simvastatin has been shown to reduce both normal and elevated LDL-C concentrations.
	Read more about Simvastatin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CHOLIB Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10BA04	Simvastatin and fenofibrate	C Cardiovascular system → C10 Lipid modifying agents → C10B Lipid modifying agents, combinations → C10BA Combinations of various lipid modifying agents
Discover more medicines within C10BA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1624047, 1624058, 1624069, 1624070, 1676000, 1676011
GB	Medicines & Healthcare Products Regulatory Agency	321701, 321711
HK	Department of Health Drug Office	66374, 66375
LT	Valstybinė vaistų kontrolės tarnyba	1071169, 1071170, 1071171, 1071172, 1075159, 1075160
PL	Rejestru Produktów Leczniczych	100302695, 100302703
SG	Health Sciences Authority	15664P